Teacher Retirement System of Texas reduced its position in shares of Mallinckrodt PLC (NYSE:MNK) by 0.0% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 569,611 shares of the company’s stock after selling 14 shares during the period. Teacher Retirement System of Texas owned approximately 0.57% of Mallinckrodt PLC worth $25,524,000 as of its most recent filing with the SEC.
Other large investors have also modified their holdings of the company. Vanguard Group Inc. increased its stake in shares of Mallinckrodt PLC by 1.0% in the first quarter. Vanguard Group Inc. now owns 10,247,891 shares of the company’s stock worth $456,748,000 after buying an additional 103,924 shares during the last quarter. BlackRock Inc. increased its stake in shares of Mallinckrodt PLC by 4,060.7% in the first quarter. BlackRock Inc. now owns 8,734,709 shares of the company’s stock worth $389,307,000 after buying an additional 8,524,773 shares during the last quarter. State Street Corp increased its stake in shares of Mallinckrodt PLC by 5.1% in the first quarter. State Street Corp now owns 5,197,656 shares of the company’s stock worth $231,654,000 after buying an additional 250,838 shares during the last quarter. Alliancebernstein L.P. increased its stake in shares of Mallinckrodt PLC by 1,455.5% in the first quarter. Alliancebernstein L.P. now owns 2,900,796 shares of the company’s stock worth $129,288,000 after buying an additional 2,714,313 shares during the last quarter. Finally, Dimensional Fund Advisors LP increased its stake in shares of Mallinckrodt PLC by 12.1% in the first quarter. Dimensional Fund Advisors LP now owns 1,614,565 shares of the company’s stock worth $71,968,000 after buying an additional 174,712 shares during the last quarter. 95.71% of the stock is owned by institutional investors.
Mallinckrodt PLC (NYSE MNK) opened at 36.52 on Friday. The firm’s market cap is $3.55 billion. The stock has a 50 day moving average price of $43.88 and a 200-day moving average price of $45.56. Mallinckrodt PLC has a one year low of $36.02 and a one year high of $85.83.
Mallinckrodt PLC (NYSE:MNK) last released its quarterly earnings results on Tuesday, August 8th. The company reported $1.85 EPS for the quarter, topping the Zacks’ consensus estimate of $1.73 by $0.12. The company had revenue of $824.50 million for the quarter, compared to analyst estimates of $829.56 million. Mallinckrodt PLC had a return on equity of 15.28% and a net margin of 12.64%. Mallinckrodt PLC’s revenue was down 4.9% compared to the same quarter last year. During the same quarter last year, the firm posted $2.03 earnings per share. Analysts predict that Mallinckrodt PLC will post $7.48 EPS for the current fiscal year.
Several analysts have issued reports on the company. Deutsche Bank AG set a $56.00 price objective on Mallinckrodt PLC and gave the stock a “buy” rating in a report on Wednesday. Jefferies Group LLC restated a “buy” rating and set a $70.00 price objective on shares of Mallinckrodt PLC in a report on Friday, April 21st. Piper Jaffray Companies set a $85.00 price objective on Mallinckrodt PLC and gave the stock a “buy” rating in a report on Monday, August 7th. Oppenheimer Holdings, Inc. set a $70.00 price objective on Mallinckrodt PLC and gave the stock a “buy” rating in a report on Friday, July 28th. Finally, Raymond James Financial, Inc. cut their price objective on Mallinckrodt PLC from $65.00 to $58.00 and set an “outperform” rating on the stock in a report on Wednesday. Two equities research analysts have rated the stock with a sell rating, five have issued a hold rating and sixteen have issued a buy rating to the company’s stock. Mallinckrodt PLC currently has a consensus rating of “Buy” and an average price target of $72.44.
In other Mallinckrodt PLC news, VP Coleman N. Lannum III purchased 1,350 shares of the company’s stock in a transaction dated Friday, June 2nd. The shares were bought at an average price of $42.89 per share, with a total value of $57,901.50. Following the completion of the transaction, the vice president now directly owns 30,955 shares in the company, valued at approximately $1,327,659.95. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, VP Steven J. Romano purchased 1,000 shares of the company’s stock in a transaction dated Friday, June 9th. The shares were acquired at an average cost of $39.88 per share, for a total transaction of $39,880.00. The disclosure for this purchase can be found here. In the last ninety days, insiders have bought 3,850 shares of company stock worth $157,687. 0.77% of the stock is currently owned by insiders.
About Mallinckrodt PLC
Mallinckrodt public limited company develops, manufactures, markets and distributes branded and generic specialty pharmaceutical products and therapies. The Company focuses on various therapeutic areas, such as autoimmune and rare disease specialty areas, including neurology, rheumatology, nephrology, ophthalmology and pulmonology; immunotherapy and neonatal critical care respiratory therapies; analgesics and hemostasis products, and central nervous system drugs.
Want to see what other hedge funds are holding MNK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mallinckrodt PLC (NYSE:MNK).
Receive News & Ratings for Mallinckrodt PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mallinckrodt PLC and related companies with MarketBeat.com's FREE daily email newsletter.